Suppr超能文献

库欣病的经蝶窦重复手术

Repeat transsphenoidal surgery for Cushing's disease.

作者信息

Friedman R B, Oldfield E H, Nieman L K, Chrousos G P, Doppman J L, Cutler G B, Loriaux D L

机构信息

Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland.

出版信息

J Neurosurg. 1989 Oct;71(4):520-7. doi: 10.3171/jns.1989.71.4.0520.

Abstract

Transsphenoidal resection of adrenocorticotrophic hormone (ACTH)-producing pituitary adenomas has the potential of curing most patients with Cushing's disease. However, transsphenoidal exploration of the pituitary is not always curative, and patients who have remission of hypercortisolism following surgery occasionally develop a recurrence. Whether repeat pituitary surgery should be performed for recurrent or persistent Cushing's disease has not been evaluated previously. To determine the efficacy of transsphenoidal surgery in recurrent or persistent Cushing's disease, we performed transsphenoidal surgery in 31 patients (22 women and nine men) who had previously undergone a transsphenoidal operation and two female patients who had had previous pituitary irradiation only. In 24 (73%) of the 33 patients, remission of hypercortisolism was achieved by surgery. Although preoperative computerized tomography (CT) scanning identified an adenoma in only three of the 33 patients, in 20 patients a discrete adenoma was identified at pituitary exploration. The incidence of hypercortisolism was greatest if an adenoma was identified at surgery and the patient received selective adenomectomy (19, or 95% of 20 patients), if there was evidence at surgery or by preoperative CT scanning that the previous surgical exposure of the pituitary was incomplete (seven, or 78% of nine patients), if an adenoma was seen on preoperative CT scanning (three of three patients), or if the patient had had prior pituitary irradiation without surgery (two of two patients). In contrast, only five (42%) of 12 patients who received subtotal or total hypophysectomy had remission of hypercortisolim. Surgically induced hypopituitarism occurred in six (50%) of these 12 patients, but in only one (5%) of the 20 patients who underwent selective adenomectomy. Three (13%) of the 24 patients who were in remission from hypercortisolims following repeat surgery developed recurrent hypercortisolism 10 to 47 months postoperatively. Repeat transsphenoidal exploration of the pituitary and treatment limited to selective adenomectomy should be considered in patients with hypercortisolism despite previous pituitary treatment. If an adenoma is identified during surgery, the chance of remission of Cushing's disease is high and the risk of hypopituitarism is low; however, if no adenoma can be found and partial or complete hypophysectomy is performed, remission of hypercortisolism is less likely and the risk of hypopituitarism is about 50%.

摘要

经蝶窦切除产生促肾上腺皮质激素(ACTH)的垂体腺瘤有可能治愈大多数库欣病患者。然而,垂体的经蝶窦探查并不总是能治愈疾病,术后高皮质醇血症缓解的患者偶尔会复发。对于复发性或持续性库欣病是否应进行再次垂体手术,此前尚未进行评估。为了确定经蝶窦手术治疗复发性或持续性库欣病的疗效,我们对31例(22例女性和9例男性)曾接受过经蝶窦手术的患者以及2例仅接受过垂体放疗的女性患者进行了经蝶窦手术。33例患者中有24例(73%)通过手术实现了高皮质醇血症的缓解。尽管术前计算机断层扫描(CT)仅在33例患者中的3例发现了腺瘤,但在20例患者的垂体探查中发现了孤立的腺瘤。如果在手术中发现腺瘤且患者接受了选择性腺瘤切除术(20例患者中的19例,即95%),如果手术中有证据或术前CT扫描显示先前垂体手术暴露不完整(9例患者中的7例,即78%),如果术前CT扫描发现腺瘤(3例患者中的3例),或者如果患者先前仅接受过垂体放疗而未进行手术(2例患者中的2例),高皮质醇血症的发生率最高。相比之下,接受次全或全垂体切除术的12例患者中只有5例(42%)实现了高皮质醇血症的缓解。这12例患者中有6例(50%)发生了手术诱发的垂体功能减退,但在接受选择性腺瘤切除术的20例患者中只有1例(5%)发生。24例术后高皮质醇血症缓解的患者中有3例(13%)在术后10至47个月出现了复发性高皮质醇血症。对于尽管先前接受过垂体治疗但仍有高皮质醇血症的患者,应考虑再次经蝶窦探查垂体并仅进行选择性腺瘤切除术。如果在手术中发现腺瘤,库欣病缓解的机会很高且垂体功能减退的风险很低;然而,如果未发现腺瘤且进行了部分或全垂体切除术,高皮质醇血症缓解的可能性较小且垂体功能减退的风险约为50%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验